We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$86.7B
AUM Growth
-$17.2B
Cap. Flow
-$19.4B
Cap. Flow %
-22.34%
Top 10 Hldgs %
24.65%
Holding
7,637
New
330
Increased
2,121
Reduced
4,377
Closed
488

Sector Composition

Rank Sector Weight
1 Healthcare 7.58%
2 Technology 5.48%
3 Financials 4.9%
4 Energy 3.61%
5 Consumer Discretionary 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWH icon
5476
Sportsman's Warehouse
SPWH
$46M
$29K ﹤0.01%
4,100
-5,055
-55% -$37.3K
UYM icon
5477
CALL
ProShares Ultra Materials
UYM
$40.9M
$29K ﹤0.01%
2,400
-1,600
-40% -$20.1K
MTBL
5478
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$29K ﹤0.01%
9,533
-28,734
-75% -$110K
INFI
5479
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$29K ﹤0.01%
2,291
-6,950
-75% -$106K
GHDX
5480
DELISTED
Genomic Health, Inc.
GHDX
$29K ﹤0.01%
965
-1,285
-57% -$40.8K
KLXI
5481
PUT
DELISTED
KLX Inc.
KLXI
$29K ﹤0.01%
890
-6,048
-87% -$202K
EXAR
5482
DELISTED
Exar Corporation
EXAR
$29K ﹤0.01%
2,887
-6,963
-71% -$71.2K
CBR
5483
DELISTED
CIBER Inc.
CBR
$29K ﹤0.01%
7,234
+2,813
+64% +$10.5K
SGI
5484
CALL
DELISTED
Silicon Graphics Intl.
SGI
$29K ﹤0.01%
3,600
-900
-20% -$8.87K
MCF
5485
DELISTED
Contango Oil & Gas Co.
MCF
$29K ﹤0.01%
1,310
-5,274
-80% -$136K
CEO
5486
DELISTED
CNOOC Limited
CEO
$29K ﹤0.01%
205
-17,380
-99% -$2.4M
ENOV icon
5487
CALL
Enovis
ENOV
$1.53B
$28K ﹤0.01%
349
-1,104
-76% -$92.5K
EPC icon
5488
PUT
Edgewell Personal Care
EPC
$1.31B
$28K ﹤0.01%
270
+135
+100% +$13.4K
FSS icon
5489
Federal Signal
FSS
$7.83B
$28K ﹤0.01%
1,886
-6,484
-77% -$101K
HLIO icon
5490
Helios Technologies
HLIO
$2.76B
$28K ﹤0.01%
665
-602
-48% -$23.3K
IDT icon
5491
IDT Corp
IDT
$1.62B
$28K ﹤0.01%
2,267
-30
-1% -$436
NCMI icon
5492
National CineMedia
NCMI
$378M
$28K ﹤0.01%
182
-165
-48% -$24.6K
QLYS icon
5493
Qualys
QLYS
$6.35B
$28K ﹤0.01%
602
-1,031
-63% -$44.1K
SRPT icon
5494
Sarepta Therapeutics
SRPT
$1.77B
$28K ﹤0.01%
2,155
-1,762
-45% -$23.5K
TCRT icon
5495
Alaunos Therapeutics
TCRT
$4.86M
$28K ﹤0.01%
19
-1,926
-99% -$2.85M
VRTS icon
5496
Virtus Investment Partners
VRTS
$1.1B
$28K ﹤0.01%
211
-4,371
-95% -$617K
WNS
5497
DELISTED
WNS Holdings
WNS
$28K ﹤0.01%
1,130
-4,164
-79% -$97K
CIR
5498
DELISTED
CIRCOR International, Inc
CIR
$28K ﹤0.01%
531
-474
-47% -$25.2K
XLRN
5499
DELISTED
Acceleron Pharma
XLRN
$28K ﹤0.01%
729
-786
-52% -$31.3K
SYKE
5500
DELISTED
SYKES Enterprises Inc
SYKE
$28K ﹤0.01%
1,185
-4,932
-81% -$116K

Similar funds

Barclays's Q1 2015 Portfolio in Review

As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.

Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.

  • Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
  • Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
  • Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
  • Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
  • Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
  • Barclays opened 330 new positions and closed 488 in Q1 2015.
  • Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.